HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. [electronic resource]
Producer: 20090130Description: 19183-7 p. digitalISSN:- 1091-6490
- Animals
- Benzamides -- pharmacology
- Cells, Cultured
- Enzyme Inhibitors -- pharmacology
- Epigenesis, Genetic
- Histone Deacetylase 2
- Histone Deacetylase Inhibitors
- Histone Deacetylases -- genetics
- Mice
- Mice, Inbred C57BL
- Mice, Inbred mdx
- Muscle, Skeletal -- cytology
- Muscular Dystrophy, Animal -- drug therapy
- Muscular Dystrophy, Duchenne -- drug therapy
- Myoblasts -- cytology
- Nitric Oxide -- metabolism
- Nitrogen -- metabolism
- Pyridines -- pharmacology
- RNA, Small Interfering
- Repressor Proteins -- antagonists & inhibitors
- Satellite Cells, Skeletal Muscle -- cytology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.